1.  Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas - Nigeria, 2016.

Nnadi C, Damisa E, Esapa L, Braka F, Waziri N, Siddique A, Jorba J, Nganda GW, Ohuabunwo C, Bolu O, Wiesen E, Adamu U.

MMWR Morb Mortal Wkly Rep. 2017 Feb 24;66(7):190-193. doi: 10.15585/mmwr.mm6607a2.

https://www.cdc.gov/mmwr/volumes/66/wr/mm6607a2.htm

2.  Wild poliovirus in Nigeria.

Zoakah AI, Adebiyi AO, Ashikeni M, Makinde OA; Epidemiological Society of Nigeria (EPiSON).

Lancet Infect Dis. 2016 Nov;16(11):1224. doi: 10.1016/S1473-3099(16)30391-7. No abstract available.

https://www.thelancet.com/action/showPdf?pii=S1473-3099%2816%2930391-7

3.   Progress Toward Poliomyelitis Eradication - Nigeria, January-December 2017.

Bolu O, Nnadi C, Damisa E, Braka F, Siddique A, Archer WR, Bammeke P, Banda R, Higgins J, Edukugo A, Nganda GW, Forbi JC, Liu H, Gidado S, Soghaier M, Franka R, Waziri N, Burns CC, Vertefeuille J, Wiesen E, Adamu U.

MMWR Morb Mortal Wkly Rep. 2018 Mar 2;67(8):253-256. doi: 10.15585/mmwr.mm6708a5.

https://www.cdc.gov/mmwr/volumes/67/wr/mm6708a5.htm

4.  Nigeria polio endgame impeded by Boko Haram.

Webster P.

CMAJ. 2017 Jun 26;189(25):E877-E878. doi: 10.1503/cmaj.1095433. No abstract available.

http://www.cmaj.ca/content/189/25/E877/F1

5.  Polio eradication efforts in regions of geopolitical strife: the Boko Haram threat to efforts in sub-Saharan Africa.

Bigna JJ.

Afr Health Sci. 2016 Jun;16(2):584-7. doi: 10.4314/ahs.v16i2.28.

https://www.ajol.info/index.php/ahs/article/view/138628

6.  Why have the majority of recent polio cases occurred in countries affected by Islamist militancy? A historical comparative analysis of the political determinants of polio in Nigeria, Somalia, Pakistan, Afghanistan and Syria.

Kennedy J.

Med Confl Surviv. 2016 Oct-Dec;32(4):295-316. doi: 10.1080/13623699.2017.1294338. Epub 2017 Mar 7.

https://www.tandfonline.com/doi/abs/10.1080/13623699.2017.1294338?journalCode=fmcs20

7.  Approaches to Vaccination Among Populations in Areas of Conflict.

Nnadi C, Etsano A, Uba B, Ohuabunwo C, Melton M, Wa Nganda G, Esapa L, Bolu O, Mahoney F, Vertefeuille J, Wiesen E, Durry E.

J Infect Dis. 2017 Jul 1;216(suppl_1):S368-S372. doi: 10.1093/infdis/jix175.

https://academic.oup.com/jid/article/216/suppl_1/S368/3935080

8.  Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.

Thompson KM, Duintjer Tebbens RJ.

J Infect Dis. 2017 Jul 1;216(suppl_1):S176-S182. doi: 10.1093/infdis/jix108.

https://academic.oup.com/jid/article/216/suppl_1/S176/3935072

9.  Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April-November 2015.

Osadebe LU, MacNeil A, Elmousaad H, Davis L, Idris JM, Haladu SA, Adeoye OB, Nguku P, Aliu-Mamudu U, Hassan E, Vertefeuille J, Bloland P.

J Infect Dis. 2017 Jul 1;216(suppl_1):S137-S145. doi: 10.1093/infdis/jix044.

https://academic.oup.com/jid/article/216/suppl_1/S137/3935063

1. Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria.

Scotney S, Snidal S, Saidu Y, Ojumu A, Ngatia A, Bagana M, Mutuku F, Sobngwi J, Efe-Aluta O, Roper J, LeTallec Y, Kangethe A.

J Infect Dis. 2017 Jul 1;216(suppl_1):S130-S136. doi: 10.1093/infdis/jiw544.

https://academic.oup.com/jid/article/216/suppl_1/S130/3935033

1. Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016.

Shirreff G, Wadood MZ, Vaz RG, Sutter RW, Grassly NC.

Emerg Infect Dis. 2017 Feb;23(2):258-263. doi: 10.3201/eid2302.161210. Epub 2017 Feb 15.

https://wwwnc.cdc.gov/eid/article/23/2/16-1210_article

1. Polio Legacy in Action: Using the Polio Eradication Infrastructure for Measles Elimination in Nigeria-The National Stop Transmission of Polio Program.

Michael CA, Waziri N, Gunnala R, Biya O, Kretsinger K, Wiesen E, Goodson JL, Esapa L, Gidado S, Uba B, Nguku P, Cochi S.

J Infect Dis. 2017 Jul 1;216(suppl_1):S373-S379. doi: 10.1093/infdis/jix014.

https://academic.oup.com/jid/article/216/suppl_1/S373/3935059

1. Lessons Learned and Legacy of the Stop Transmission of Polio Program.

Kerr Y, Mailhot M, Williams AAJ, Swezy V, Quick L, Tangermann RH, Ward K, Benke A, Callaghan A, Clark K, Emery B, Nix J, Aydlotte E, Newman C, Nkowane B.

J Infect Dis. 2017 Jul 1;216(suppl_1):S316-S323. doi: 10.1093/infdis/jix163.

https://academic.oup.com/jid/article/216/suppl_1/S316/3935078

1. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.

Ongwae KM, Bawa SB, Shuaib F, Braka F, Corkum M, Isa HK.

J Infect Dis. 2017 Jul 1;216(suppl_1):S267-S272. doi: 10.1093/infdis/jiw520.

https://academic.oup.com/jid/article/216/suppl_1/S267/3935032

1. Children who have received no routine polio vaccines in Nigeria: Who are they and where do they live?

Uthman OA, Adedokun ST, Olukade T, Watson S, Adetokunboh O, Adeniran A, Oyetoyan SA, Gidado S, Lawoko S, Wiysonge CS.

Hum Vaccin Immunother. 2017 Sep 2;13(9):2111-2122. doi: 10.1080/21645515.2017.1336590. Epub 2017 Jun 30.

https://www.tandfonline.com/doi/abs/10.1080/21645515.2017.1336590?journalCode=khvi20

1. Understanding vaccine hesitancy in polio eradication in northern Nigeria.

Taylor S, Khan M, Muhammad A, Akpala O, van Strien M, Morry C, Feek W, Ogden E.

Vaccine. 2017 Nov 7;35(47):6438-6443. doi: 10.1016/j.vaccine.2017.09.075. Epub 2017 Oct 12.

https://www.ncbi.nlm.nih.gov/pubmed/29031691

1. Progress Toward Containment of Poliovirus Type 2 - Worldwide, 2017.

Previsani N, Singh H, St Pierre J, Boualam L, Fournier-Caruana J, Sutter RW, Zaffran M; MEng.

MMWR Morb Mortal Wkly Rep. 2017 Jun 23;66(24):649-652. doi: 10.15585/mmwr.mm6624a5.

https://www.cdc.gov/mmwr/volumes/66/wr/mm6624a5.htm

1. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.

Lopalco PL.

Epidemiol Infect. 2017 Feb;145(3):413-419. doi: 10.1017/S0950268816002569. Epub 2016 Nov 21. Review.

https://www.cambridge.org/core/journals/epidemiology-and-infection/article/wild-and-vaccinederived-poliovirus-circulation-and-implications-for-polio-eradication/BE11533DDCD3230651B65EA6F545FAC1

1. Spatial Dynamics and High Risk Transmission Pathways of Poliovirus in Nigeria 2001-2013.

Mangal TD, Aylward RB, Shuaib F, Mwanza M, Pate MA, Abanida E, Grassly NC.

PLoS One. 2016 Sep 26;11(9):e0163065. doi: 10.1371/journal.pone.0163065. eCollection 2016.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0163065

1. Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria.

Iliyasu Z, Verma H, Craig KT, Nwaze E, Ahmad-Shehu A, Jibir BW, Gwarzo GD, Gajida AU, Weldon WC, Steven Oberste M, Takane M, Mkanda P, Muhammad AJG, Sutter RW.

Vaccine. 2016 Sep 30;34(42):5125-5131. doi: 10.1016/j.vaccine.2016.08.058. Epub 2016 Aug 31.

https://www.sciencedirect.com/science/article/pii/S0264410X16307459?via%3Dihub

1. Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.

Etsano A, Damisa E, Shuaib F, Nganda GW, Enemaku O, Usman S, Adeniji A, Jorba J, Iber J, Ohuabunwo C, Nnadi C, Wiesen E.

MMWR Morb Mortal Wkly Rep. 2016 Aug 5;65(30):770-3. doi: 10.15585/mmwr.mm6530a4

https://www.cdc.gov/mmwr/volumes/65/wr/mm6530a4.htm